2012 Economic Outlook -- Report Highlights Alexion Pharmaceuticals, Inc. and Cree, Inc.

Marketwired

HONG KONG--(Marketwire -02/13/12)- Today, www.BrightonMarkets.com announced new reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN - News) and Cree, Inc. (NASDAQ: CREE - News). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=ALXN&cob=CREE.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Alexion Pharmaceuticals, Inc. for its current position within the healthcare industry. Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ophthalmology and cancer. The full research report on Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN - News) is available here: www.BrightonMarkets.com/index.php?coa=ALXN.

Brighton Markets has released research on Cree, Inc. for its changing role within the technology industry. Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds. It focuses its expertise in SiC and GaN on light emitting diode (LED) products. It also develops power and radio frequency (RF) products. The full research report on Cree, Inc. (NASDAQ: CREE - News) is available here: www.BrightonMarkets.com/index.php?cob=CREE.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact:
View Comments (0)